Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Int J Radiat Biol. 2023 Nov 27;100(3):466–485. doi: 10.1080/09553002.2023.2283089

Table 1.

Workshop Speakers and areas of expertise.

Name Affiliation Area of Expertise
Sally A. Amundson, PhD Columbia University Irving Medical Center Radiation transcriptomics, biomarkers, cancer biology, radiation protection, biodosimetry
Dina A. Andrews, DVM, PhD, DACVP Amgen, Inc. Translational safety & bioanalytical sciences, clinical pathology, non-clinical safety, veterinary pathology
Tyler A. Beach, PhD SRI International (SRI) Toxicology and radiation biology, RNA sequencing, histology, flow cytometry, and molecular biology
Jeremy B. Brower, PhD Lovelace Biomedical Research Institute Drug development, pre-clinical CBRNE animal models, toxicology, and pulmonary disease
Amrita K. Cheema, PhD Georgetown University Oncology, molecular biology, biochemistry, DNA repair, multi-omics, and radiation research
Janine A. Clayton, MD NIH Office of Research on Women’s Health (ORWH) Ophthalmology, NIH policy, sex and gender in health and disease
J. Mark Cline, DVM, PhD Wake Forest School of Medicine Veterinary pathology, animal models of cancer and radiation effects, breast and reproductive cancer risk, non-human primates
Julia R. Coleman, MD, MPH University of Colorado Health Science Center Trauma surgery, surgical critical care, sex dimorphisms in coagulation,
C. Norman Coleman, MD National Cancer Institute (NCI) Medical and radiation oncology, global health security, radiological-nuclear threats, biomarkers
Vishwa Deep Dixit, DVM, PhD Yale School of Medicine Immunobiology, immune-metabolism and aging, immune-senescence, metabolic dysfunction
Anne-Marie Downey, PhD Charles River Labs (CRL) Radiation-related preclinical studies, pharmacology
Melanie L. Doyle-Eisele, PhD Lovelace Biomedical Research Institute (LBRI) Drug development, pre-clinical CBRNE animal models, PK/PD, toxicology, pulmonary disease, infectious disease, inflammation, and injury
S. Robin Elgart, PhD NASA Human Research Program Microbiology, DNA damage response, medical physics, and radiation biology
Sanchita P. Ghosh, PhD Armed Forces Radiobiology Research Institute (AFRRI) Radiation countermeasures, molecular markers of radiation injury, DEARE
Heather A. Himburg, PhD Medical College of Wisconsin Hematology, oncology, normal tissue radiation-induced injury, immune system, tumor radioresistance, DEARE
Carol J. Iddins, MD Radiation Emergency Assistance Center/Training Site (REAC/TS) Radiation emergency management, radiological security and safety, disaster medicine, obstetrics and gynecology, occupational medicine, military operational and aerospace medicine
Isabel L. Jackson, PhD University of Maryland, School of Medicine (UMSOM) Normal tissue radiobiology, animal models of ARS/DEARE, MCM development under the FDA Animal Rule
Maureen A. Kane, PhD University of Maryland, School of Pharmacy Analytical chemistry, targeted metabolomics,
lipidomics, proteomics, mass spectrometry imaging, biomarkers
Evagelia C. Laiakis, PhD Georgetown University Human genetics, radiation biodosimetry, metabolomics, lipidomics, and space radiation effects
Naresh Menon, PhD ChromoLogic, LLC Sensor fabrication, instrumentation and novel data analytic methods, wound care and infectious disease, diagnostics/screening, drug delivery, and telehealth
Andrea M. Patterson, PhD Indiana University School of Medicine Hematology, oncology, microbiology, immunology, radioprotection and radiomitigation, age specific animal models
Subhrajit Saha, MTech, PhD University of Kansas Medical Center Radiation oncology, regenerative medicine, and organoids
Alla Shapiro, MD, PhD Consultant Pediatric hematology oncology
Kaveeta Parikh Vasisht, MD, Pharm.D FDA Office of Women’s Health Internal medicine and adult endocrinology, scientific programing in women’s health, and policy development
Gordana Vunjak-Novakovic, PhD Columbia University Biomedical engineering, regenerative medicine, and organs-on-a-chip
Stephanie Zalesak-Kravec, BS University of Maryland, Baltimore, School of Pharmacy Biochemistry, innovative analytical chemistry platforms, mass spectrometry, cardiac, and immune disorders